Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 7;10(1):25.
doi: 10.3390/jcdd10010025.

The Cost Effectiveness of Coronary CT Angiography and the Effective Utilization of CT-Fractional Flow Reserve in the Diagnosis of Coronary Artery Disease

Affiliations
Review

The Cost Effectiveness of Coronary CT Angiography and the Effective Utilization of CT-Fractional Flow Reserve in the Diagnosis of Coronary Artery Disease

Rex A Burch et al. J Cardiovasc Dev Dis. .

Abstract

Given the high global disease burden of coronary artery disease (CAD), a major problem facing healthcare economic policy is identifying the most cost-effective diagnostic strategy for patients with suspected CAD. The aim of this review is to assess the long-term cost-effectiveness of coronary computed tomography angiography (CCTA) when compared with other diagnostic modalities and to define the cost and effective diagnostic utilization of computed tomography-fractional flow reserve (CT-FFR). A search was conducted through the MEDLINE database using PubMed with 16 of 119 manuscripts fitting the inclusion and exclusion criteria for review. An analysis of the data included in this review suggests that CCTA is a cost-effective strategy for both low risk acute chest pain patients presenting to the emergency department (ED) and low-to-intermediate risk stable chest pain outpatients. For patients with intermediate-to-high risk, CT-FFR is superior to CCTA in identifying clinically significant stenosis. In low-to-intermediate risk patients, CCTA provides a cost-effective diagnostic strategy with the potential to reduce economic burden and improve long-term health outcomes. CT-FFR should be utilized in intermediate-to-high risk patients with stenosis of uncertain clinical significance. Long-term analysis of cost-effectiveness and diagnostic utility is needed to determine the optimal balance between the cost-effectiveness and diagnostic utility of CT-FFR.

Keywords: cardiovascular heart disease; coronary artery disease (CAD); coronary computed tomography angiography (CCTA); cost analysis; cost-effectiveness analysis (CEA); ischemic heart disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram summarizing the identification of included studies.

References

    1. Sanchis-Gomar F., Perez-Quilis C., Leischik R., Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann. Transl. Med. 2016;4:256. doi: 10.21037/atm.2016.06.33. - DOI - PMC - PubMed
    1. Hernandez L., Shah A., Zhao Q., Milentijevic D., Kharat A. Economic implications of preventing major cardiovascular and limb events with rivaroxaban plus aspirin in patients with coronary or peripheral artery disease in the United States. Am. Health Drug Benefits. 2020;13:184–190. - PMC - PubMed
    1. Smith S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;11:2363–2372. doi: 10.1161/CIRCULATIONAHA.106.174516. - DOI - PubMed
    1. De Beule T., Vanhoenacker P., De Booij M., Ardies L., Bladt O. Cost effectiveness of multi detector ct angiography of the coronary arteries for the diagnosis of suspected non-st elevation acute coronary syndrome (NSTE-ACS) in the emergency department. Mathematical analysis with a decision model. JBR-BTR. 2010;93:285. doi: 10.5334/jbr-btr.341. - DOI - PubMed
    1. Berger A., Simpson A., Bhagnani T., Leeper N.J., Murphy B., Nordstrom B., Ting W., Zhao Q., Berger J.S. Incidence and cost of major adverse cardiovascular events and major adverse limb events in patients with chronic coronary artery disease or peripheral artery disease. Am. J. Cardiol. 2019;123:1893–1899. doi: 10.1016/j.amjcard.2019.03.022. - DOI - PubMed

LinkOut - more resources